Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Thiabendazole anticorps

Reactivité: Chemical EIA Hôte: Mouton Polyclonal unconjugated
N° du produit ABIN487924
  • Antigène
    Thiabendazole
    Reactivité
    Chemical
    Hôte
    • 1
    Mouton
    Clonalité
    • 1
    Polyclonal
    Conjugué
    • 1
    Inconjugué
    Application
    • 1
    • 1
    • 1
    • 1
    • 1
    Enzyme Immunoassay (EIA)
    Purification
    Ig Fraction
    Immunogène
    Thiabendazole (5)-BTG
    Isotype
    IgG
  • Indications d'application
    ELISA: 5.0 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    7.36 mg/mL (U.V.abs at 280nm)
    Buffer
    20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2, 0.09 % Sodium Azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    -20 °C
  • Antigène
    Thiabendazole
    Classe de substances
    Chemical
    Sujet
    Anthelmintics or anti-helminthics are a class of drugs that are effective against a range of intestinal parasitic worms (helminths). Parasitic helminths must maintain an appropriate feeding site. Nematodes and trematodes must actively ingest and move food through their digestive tracts to maintain an appropriate energy state, these together with reproductive processes require a well defined and developed neuromuscular coordination. Anthelmintic treatment is a multi-targeting system designed to interfere with the integrity of parasite cells. The pharmacologic basis of the treatment for helminths involves the targeting of neuromuscular coordination, or protective mechanisms against host immunity, which lead to starvation, paralysis, and expulsion of the parasite. The benzimidazole class of drugs were introduced in 1961 and interfere with the parasite's ATP pathway on a cellular level. They bind to a specific building block called b-tubulin and prevent its incorporation into certain cellular structures called microtubules, which are essential for energy metabolism.Synonyms: 3-thiazole, 4-(1H-benzimidazol-2-yl)-1, Arbotect, Lombristop, Mintesol, Mintezol, Omnizole, TBZ, Thiabenzole, Thibenzol, Tiabendazole, Tresaderm
Vous êtes ici:
Support technique